← Back to Discover
Affinity Asset Advisors, LLC
Period ended Jun 30, 2026 · Latest filing Aug 13, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,212,480,490
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $132,712,500
- APOGEE THERAPEUTICS INC · COM · 03770N101 · shares: $131,004,510
- SPYRE THERAPEUTICS INC · COM NEW · 00773J202 · shares: $113,561,517
- XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $96,274,200
- ERASCA INC · COM · 29479A108 · shares: $96,180,000
- INSMED INC · COM PAR $.01 · 457669307 · shares: $69,303,000
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $61,936,150
- ALKERMES PLC · SHS · G01767105 · shares: $58,944,375
- ORUKA THERAPEUTICS INC · COM · 687604108 · shares: $56,150,300
- ANAPTYSBIO INC · COM · 032724106 · shares: $55,762,358
Reported holdings
113 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SPRUCE BIOSCIENCES INC | COM NEW | 85209E208 | — | 30,000 shares | $1,620,000 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | CALL | 100,000 shares | $1,457,000 |
| EIKON THERAPEUTICS INC | COM | 282564103 | — | 98,001 shares | $1,278,913 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 240,963 shares | $1,098,791 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 600,000 shares | $1,038,000 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 145,000 shares | $677,150 |
| BOUNDLESS BIO INC | COM | 10170A100 | — | 250,000 shares | $625,000 |
| LENZ THERAPEUTICS INC | COM | 52635N103 | — | 100,000 shares | $568,000 |
| Q32 BIO INC | COM | 746964105 | — | 27,777 shares | $353,879 |
| ORCHESTRA BIOMED HLDGS INC | COM | 68572M106 | — | 33,400 shares | $144,121 |
| NEXTCURE INC | COM NEW | 65343E207 | — | 41,960 shares | $67,136 |
| ADAGIO MED HLDGS INC | COM | 00534B100 | — | 80,000 shares | $52,128 |
| ROCKET PHARMACEUTICALS INC | *W EXP 09/02/202 | 77313F114 | — | 75,000 shares | $278 |